ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY

被引：0
|
作者：
Tsuji, Daiki [1 ]
Kim, Yong-Il [2 ]
Daimon, Takashi [3 ]
Makuta, Ryo [1 ]
Homma, Chiho [2 ]
Nakamichi, Hidenori [4 ]
Yamamoto, Keisuke [4 ]
Hayashi, Hideki [1 ]
Inoue, Kazuyuki [1 ]
Itoh, Kunihiko [1 ]
机构：
[1] Univ Shizuoka, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan
[2] Seirei Hamamatsu Gen Hosp, Dept Med Oncol, Hamamatsu, Shizuoka, Japan
[3] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo, Japan
[4] Seirei Hamamatsu Gen Hosp, Dept Pharm, Hamamatsu, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-26-1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antiemetic Efficacy of a Palonosetron-Dexamethasone Schedule in Pediatric Patients Treated with Moderately or Highly Emetogenic Chemotherapy
    Varrasso, G.
    De Grazia, A.
    Ferrara, E.
    Paiano, M.
    Mattiucci, C.
    Pedetti, V.
    Schiavetti, A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S550 - S550
  • [2] REDUCED RISK OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WITH CANCER TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY AND ANTIEMETIC PROPHYLAXIS WITH PALONOSETRON
    Schwartzberg, L.
    Jackson, J.
    Jain, G.
    Balu, S.
    VALUE IN HEALTH, 2011, 14 (07) : A434 - A434
  • [3] Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea
    Ryugyoung Lee
    Minhee Ku
    Nam Kyung Je
    Supportive Care in Cancer, 2024, 32
  • [4] Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea
    Lee, Ryugyoung
    Ku, Minhee
    Je, Nam Kyung
    SUPPORTIVE CARE IN CANCER, 2024, 32 (03)
  • [5] Efficacy of antiemetic regimens for prevention and treatment of chemotherapy-induced nausea and vomiting in patients of breast cancer receiving highly emetogenic chemotherapy
    Vij, Soumya
    Dhasmana, Dilip Chander
    Bala, Suman
    Verma, Sanjiv Kumar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 819 - 824
  • [6] Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy
    Mahendraratnam, Nirosha
    Farley, Joel F.
    Basch, Ethan
    Proctor, Amber
    Wheeler, Stephanie B.
    Dusetzina, Stacie B.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (12) : 4525 - 4534
  • [7] Antiemetic Regimen with Olanzapine in Pediatric Patients Receiving Highly Emetogenic Chemotherapy
    Rasheed, Azgar A.
    Bakhshi, Sameer
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 366 - 369
  • [8] Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy
    Nirosha Mahendraratnam
    Joel F. Farley
    Ethan Basch
    Amber Proctor
    Stephanie B. Wheeler
    Stacie B. Dusetzina
    Supportive Care in Cancer, 2019, 27 : 4525 - 4534
  • [9] Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC)
    O'Sullivan, Ciara C.
    Van Houten, Holly K.
    Sangaralingham, Lindsey
    Leal, Alexis D.
    Shinde, Shivani
    Liu, Hongfang
    Ettinger, David
    Loprinzi, Charles L.
    Ruddy, Kathryn J.
    CANCER RESEARCH, 2018, 78 (04)
  • [10] Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy
    Abe, Masakazu
    Kasamatsu, Yuka
    Kado, Nobuhiro
    Kuji, Shiho
    Tanaka, Aki
    Takahashi, Nobutaka
    Takekuma, Munetaka
    Hirashima, Yasuyuki
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
12345